Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients
- 1 March 1996
- journal article
- Published by Elsevier in Kidney International
- Vol. 49 (3) , 806-813
- https://doi.org/10.1038/ki.1996.112
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Citrate Anticoagulation and Divalent Cations in HemodialysisBlood Purification, 1994
- Low Molecular Weight Heparin (CY-216) versus Unfractionated Heparin in Chronic HemodialysisNephron, 1992
- Low molecular weight heparinBlood, 1992
- Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltrationKidney International, 1988
- Long-Term Comparisons of Citrate and Heparin as Anticoagulants for HemodialysisAmerican Journal of Kidney Diseases, 1987
- Severe Metabolic Alkalosis Complicating Regional Citrate HemodialysisAmerican Journal of Kidney Diseases, 1987
- Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysisThe American Journal of Medicine, 1985
- Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for BleedingNew England Journal of Medicine, 1983
- Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombinThrombosis Research, 1980
- REGIONAL ANTICOAGULATION DURING HEMODIALYSIS USING CITRATEThe Lancet Healthy Longevity, 1961